The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease

William P Hausdorff1

  • 1Worldwide Biologicals Epidemiology, GlaxoSmithKline Biologicals, Rue de l'Institut 89, B-1330 Rixensart, Belgium. william.P.Hausdorff@gsk.com

Vaccine
|October 24, 2006
PubMed

Insights

Certain pneumococcal serotypes, like 1 and 5, continue to cause severe invasive pneumococcal disease in children globally. Vaccines targeting these highly virulent serotypes are crucial for public health worldwide.

Area of Science:

  • Microbiology
  • Epidemiology
  • Immunology

Background:

  • Invasive pneumococcal disease (IPD) is a significant global health concern, particularly in children.
  • A limited number of Streptococcus pneumoniae serotypes are responsible for the majority of IPD cases.
  • Serotypes 1 and 5 have historically been prominent causes of disease and remain significant even in the antibiotic era.

Purpose of the Study:

  • To highlight the persistent importance of specific pneumococcal serotypes (1 and 5) as causes of invasive disease in children.
  • To emphasize the high virulence and public health impact of these serotypes.
  • To underscore the need for future vaccine development against these key serotypes.

Main Methods:

  • This study is a review and analysis of existing epidemiological data and scientific literature.
  • Focus is placed on historical and current disease prevalence attributed to specific pneumococcal serotypes.
  • Virulence factors and antimicrobial susceptibility patterns are considered.

Main Results:

  • Serotypes 1 and 5 are consistently identified as major contributors to invasive pneumococcal disease in children worldwide.
  • Despite the antibiotic era, these serotypes remain prevalent and cause severe illness across all age groups.
  • These serotypes exhibit high virulence, leading to disease clusters and outbreaks.

Conclusions:

  • Serotypes 1 and 5 of Streptococcus pneumoniae remain critical pathogens causing severe invasive disease in children.
  • Their continued prevalence and virulence necessitate ongoing surveillance and intervention strategies.
  • Future pneumococcal conjugate vaccines must effectively target these serotypes to reduce global disease burden.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...